Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Cardiovasc Diabetol
; 23(1): 104, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504284
3.
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes.
Cardiovasc Diabetol
; 22(1): 59, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927451
4.
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes.
Cardiovasc Diabetol
; 19(1): 185, 2020 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097060
5.
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.
Cardiovasc Diabetol
; 18(1): 115, 2019 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31472683
6.
Expert Opinion on Current Trends in the Use of Insulin in the Management of People with Type 2 Diabetes from the South-Eastern European Region and Israel.
Diabetes Ther
; 15(5): 897-915, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472626
7.
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
Eur Heart J Cardiovasc Pharmacother
; 9(2): 183-191, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639130
8.
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society.
Prog Cardiovasc Dis
; 79: 65-79, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178991
9.
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
Diabetes Res Clin Pract
; 186: 109063, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34547367
10.
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle.
Diabetes Res Clin Pract
; 153: 30-40, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31121272
11.
Editorial commentary to manuscript "Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging" by Royse et al.
J Diabetes Complications
; 36(2): 108109, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063342
12.
Predictors of response to treatment with actovegin for 6 months in patients with type 2 diabetes and symptomatic polyneuropathy.
J Diabetes Complications
; 31(7): 1181-1187, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438471
13.
Diabetes Care at the Times of Transition and COVID-19 Pandemics (Ukrainian Experience).
J Diabetes Sci Technol
; 14(4): 754-755, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32468843
14.
Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine.
J Multidiscip Healthc
; 6: 249-57, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23874102
15.
Treatment of symptomatic polyneuropathy with actovegin in type 2 diabetic patients.
Diabetes Care
; 32(8): 1479-84, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19470838
16.
4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary.
Diabetes Technol Ther
; 13(11): 1161-76, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21970820
17.
Stroke in patients with diabetes mellitus.
Diabetes Metab Res Rev
; 20(4): 268-87, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15250030